Skip to content
Star Imaging and Path Lab logo

Star Imaging and Path Lab

544482 BSE
Price unavailable

Star Imaging and Path Lab (STARIMAGIN) share price was ₹74.70 at the 28 Oct 2026 close; market capitalisation ₹130 Cr; sector Healthcare Services. The share price fell 43.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹43 Cr, against ₹41 Cr a year earlier and net profit was ₹9 Cr, against ₹10 Cr a year earlier (compared with Mar 2025). Promoters held 71.92% of Star Imaging and Path Lab in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 61/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹74.70 −62.45 −45.53% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹130 Cr
EBITDA
₹34.20 Cr
Return on Equity
16.58%
Debt to Equity
0.18
Book Value
₹66.65
EPS (TTM)
—
52W High
₹152.00
52W Low
₹46.00

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

₹1,908.4059.0132,032 Cr12.770.26%20.06%25.67%2,996 Cr545 Cr
₹1,438.2078.8914,813 Cr15.480.14%18.07%19.22%879 Cr187 Cr
₹548.7056.3911,379 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
₹514.7546.468,193 Cr15.982.84%27.79%33.84%894 Cr176 Cr
₹629.60150.266,331 Cr5.670.00%6.88%13.46%1,079 Cr85 Cr
₹318.5546.301,659 Cr6.780.16%12.90%14.70%329 Cr35 Cr
₹497.0016.301,612 Cr1.640.40%10.35%10.64%862 Cr98 Cr
——130 Cr1.120.00%16.58%22.60%——
Median 8 companies₹548.7056.397,262 Cr7.180.21%14.74%17.48%894 Cr176 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

61 Good
Overall score

Data confidence 81/100

Category scores

Quality Strong 81
Returns, margins, earnings quality 22% weight
Valuation Strong 66
Cheap vs sector & own history 24% weight
Growth Weak 44
Sales & profit trajectory 9% weight
Financial Health Good 62
Solvency, leverage, coverage 9% weight
Momentum Average 47
Trend strength, vol-adjusted 12% weight
Ownership Average 48
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Stock is trading at 1.17 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 32.1%

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 212 days.
  • Working capital days have increased from 97.5 days to 146 days

Technical Indicators

Oscillators

Neutral

Bearish
1
Neutral
7
Bullish
1

Overall

Bearish

Bearish
11
Neutral
7
Bullish
1

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
6.8% lower than 3Y

change over 1 year

Net Income Growth
20.63% lower than 3Y

change over 1 year

Cash Flow Change
987%

change over 1 year

EBITDA Margin Change
10.67%

change over 1 year Operating margin 37% · Mar 2026

Quarterly Results

Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
43
41
45
43
Expenses
31
24
28
27
Operating Profit
12
17
17
16
OPM %
27%
41%
38%
37%
Other Income
0
0
0
1
Interest
1
1
1
1
Depreciation
2
3
3
3
PBT
8
13
14
13
Tax %
25%
26%
26%
28%
Net Profit
6
10
10
9
EPS (₹)
4.6
7.19
5.77
5.3
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
69
58
79
82
86
Expenses
54
52
55
53
53
Operating Profit
15
6
23
29
33
OPM %
21%
10%
30%
35%
39%
Other Income
0
0
1
0
1
Interest
2
2
3
3
2
Depreciation
4
3
5
5
6
PBT
9
1
16
21
26
Tax %
33%
35%
23%
26%
27%
Net Profit
6
1
12
16
19
EPS (₹)
4.66
0.43
9.2
11.8
11.07
Div. Payout %
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
14
17
Reserves
17
17
30
34
99
Borrowings
30
27
31
33
21
Other Liabilities
10
16
20
18
17
Total Liabilities
58
61
82
98
154
Fixed Assets
15
19
22
21
25
CWIP
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
43
42
60
77
128
Total Assets
58
61
82
98
154
Figures in ₹ Crores

Cash Flow

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
5
18
-3
23
Investing
-4
-7
-7
-7
-13
Financing
-7
-5
2
0
36
Net Cash Flow
3
-7
13
-10
46
Free Cash Flow
10
-2
11
-7
13
CFO/EBITDA
119
95
95
10
91
Figures in ₹ Crores

Ratios

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
85
110
152
226
212
Cash Conversion Cycle
85
110
152
226
212
Working Capital Days
6
-13
23
124
146
ROCE %
—
6%
34%
34%
26%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Star Imaging and Path Lab insights

56 extracted metrics + investor summaries across FY22–FY26.

Shareholding Pattern

Govt.0.41%FIIs0.06%Promot.71.92%Others4.27%DIIs6.17%Public17.18%As ofSep 2026

Documents

Frequently Asked Questions about Star Imaging and Path Lab

What does Star Imaging and Path Lab Ltd do?
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
Where is Star Imaging and Path Lab Ltd (STARIMAGIN) listed?
Star Imaging and Path Lab Ltd trades under code 544482 on the BSE.
Which sector does Star Imaging and Path Lab Ltd belong to?
Star Imaging and Path Lab Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Star Imaging and Path Lab Ltd?
Star Imaging and Path Lab Ltd has a market capitalisation of ₹130.14 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Star Imaging and Path Lab Ltd?
Over the last 52 weeks Star Imaging and Path Lab Ltd has traded between ₹46 and ₹152 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Star Imaging and Path Lab Ltd?
Star Imaging and Path Lab Ltd reported a return on equity of 16.58%. Its debt-to-equity ratio is 0.18.

Company Information

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]

Listed 2025-08-18
Face Value ₹ 10
Shares Outstanding 1,74,21,603

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544482.md for Star Imaging and Path Lab Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More